Constitutive alternative NF-κB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen

Blood

Volumn 110, Issue 7, 2007, Pages 2381-2389

  Guo, Feng ^a   Weih, Debra ^a   Meier, Elke ^a   Weih, Falk ^a,b  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL13 CHEMOKINE; GLYCOSYLATED CELL ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LYSOPHOSPHOLIPID SPHINGOSINE 1 PHOSPHATE; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; PROTEIN; PROTEIN P100; PROTEIN P52; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CHEMOTAXIS; CONTROLLED STUDY; CORRELATION ANALYSIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINUS VENOSUS; SPLEEN;

ALLELES; ANIMALS; B-LYMPHOCYTES; CELL ADHESION; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINES; ENDOTHELIUM; GENE DELETION; INTEGRINS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; SIGNAL TRANSDUCTION; SPLEEN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 34948859010     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-02-075143     Document Type: Article

References (53)

1. Steiniger B, Barth P. Microanatomy and function of the spleen. Adv Anat Embryol Cell Biol. 2000;151:1-101.
2. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5:606-616.
3. Mebius RE, Nolte MA, Kraal G. Development and function of the splenic marginal zone. Crit Rev Immunol. 2004;24:449-464.
4. Nolte MA, Arens R, Kraus M, et al. B cells are crucial for both development and maintenance of the splenic marginal zone. J Immunol. 2004;172:3620-3627.
5. Pillai S, Cariappa A, Moran ST. Marginal zone B cells. Annu Rev Immunol. 2005;23:161-196.
6. Cyster JG. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol. 2005;23:127-159.
7. Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 2001;14:617-629.
8. Cinamon G, Matloubian M, Lesneski MJ, et al. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat Immunol. 2004;5:713-720.
9. + endothelial cells in splenic marginal sinus organization. J Exp Med. 2004;200:1491-1501.
10. Lu TT, Cyster JG. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science. 2002;297:409-412.
11. Karlsson MC, Guinamard R, Bolland S, Sankala M, Steinman RM, Ravetch JV. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J Exp Med. 2003;198:333-340.
12. Kraal G, Schornagel K, Streeter PR, Holzmann B, Butcher EC. Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen. Am J Pathol. 1995;147:763-771.
13. Miyasaka M, Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol. 2004;4:360-370.
14. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol. 2004;22:129-156.
15. Drayton DL, Ying X, Lee J, Lesslauer W, Ruddle NH. Ectopic LTαβ directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J Exp Med. 2003;197:1153-1163.
16. Drayton DL, Bonizzi G, Ying X, Liao S, Karin M, Ruddle NH. IκB kinase complex α kinase activity controls chemokine and high endothelial venule gene expression in lymph nodes and nasal-associated lymphoid tissue. J Immunol. 2004;173:6161-6168.
17. Yilmaz ZB, Weih DS, Sivakumar V, Weih F. RelB is required for Peyer's patch development: differential regulation of p52-RelB heterodimers by lymphotoxin and TNF. EMBO J. 2003;22:121-130.
18. Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev. 2004;18:2195-2224.
19. Bonizzi G, Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004;25:280-288.
20. Siebenlist U, Brown K, Claudio E. Control of lymphocyte development by nuclear factor-κB. Nat Rev Immunol. 2005;5:435-445.
21. Weih DS, Yilmaz ZB, Weih F. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J Immunol. 2001;167:1909-1919.
22. Weih F, Caamano J. Regulation of secondary lymphoid organ development by the nuclear factor-κB signal transduction pathway. Immunol Rev. 2003;195:91-105.
23. Ishikawa H, Carrasco D, Claudio E, Ryseck R-P, Bravo R. Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-κB2. J Exp Med. 1997;186:999-1014.
24. Caamaño JH, Rizzo CA, Durham SK, et al. Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med. 1998;187:185-196.
25. Franzoso G, Carlson L, Poljak L, et al. Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med. 1998;187:147-159.
26. Weih F, Carrasco D, Durham SK, et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell. 1995;80:331-340.
27. Rubtsov A, Strauch P, Digiacomo A, Hu J, Pelanda R, Torres RM. Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response. Immunity. 2005;23:527-538.
28. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol. 1999;162:7198-7207.
29. Neri A, Fracchiolla NS, Migliazza A, Trecca D, Lombardi L. The involvement of the candidate proto-oncogene NFκB2/lyt-10 in lymphoid malignancies. Leuk Lymphoma. 1996;23:43-48.
30. Dejardin E, Droin NM, Delhase M, et al. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity. 2002;17:525-535.
31. Martin F, Kearney JF. B-cell subsets and the mature preimmune repertoire: marginal zone and B1 B cells as part of a "natural immune memory." Immunol Rev. 2000;175:70-79.
32. Kraal G, Janse M. Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody. Immunology. 1986;58:665-669.
33. Elomaa O, Kangas M, Sahlberg C, et al. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell. 1995;80:603-609.
34. - cells to colonize lymph nodes. Proc Natl Acad Sci U S A. 1996;93:11019-11024.
35. Kawashima H, Petryniak B, Hiraoka N, et al. N-acetylglucosamine-6-O- sulfotransferases 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules. Nat Immunol. 2005;6:1096-1104.
36. Uchimura K, Gauguet J-M, Singer MS, et al. A major class of L-selectin ligands is eliminated in mice deficient in two sulfotransferases expressed in high endothelial venules. Nat Immunol. 2005;6:1105-1113.
37. Homeister JW, Thall AD, Petryniak B, et al. The α(1,3) fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity. 2001;15:115-126.
38. Balogh P, Horváth G, Szakal AK. Immunoarchitecture of distinct reticular fibroblastic domains in the white pulp of mouse spleen. J Histochem Cytochem. 2004;52:1287-1298.
39. Stamper HB Jr, Woodruff JJ. Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J Exp Med. 1976;144:828-833.
40. Attar RM, Caamaño J, Carrasco D, et al. Genetic approaches to study Rel/NF-κB/IκB function in mice. Semin Cancer Biol. 1997;8:93-101.
41. Mackay F, Tangye SG. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr Opin Pharmacol. 2004;4:347-354.
42. Claudio E, Brown K, Park S, Wang H, Siebenlist U. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nat Immunol. 2002;3:958-965.
43. Batten M, Groom J, Cachero TG, et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med. 2000;192:1453-1466.
44. Enzler T, Bonizzi G, Silverman GJ, et al. Alternative and classical NF-κB signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity. 2006;25:403-415.
45. Sasaki Y, Derudder E, Hobeika E, et al. Canonical NF-κB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity. 2006;24:729-739.
46. He JQ, Zarnegar B, Oganesyan G, et al. Rescue of TRAF3-null mice by p100 NF-κB deficiency. J Exp Med. 2006;203:2413-2418.
47. Lu L, Qian S, Hershberger PA, Rudert WA, Lynch DH, Thomson AW. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol. 1997;158:5676-5684.
48. Cariappa A, Liou H-C, Horwitz BH, Pillai S. Nuclear factor κB is required for the development of marginal zone B lymphocytes. J Exp Med. 2000;192:1175-1182.
49. Chen Y, Pikkarainen T, Elomaa O, et al. Defective microarchitecture of the spleen marginal zone and impaired response to a thymus-independent type 2 antigen in mice lacking scavenger receptors MARCO and SR-A. J Immunol. 2005;175:8173-8180.
50. Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol. 2006;7:344-353.
51. Browning JL, Allaire N, Ngam-Ek A, et al. Lymphotoxin-β receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity. 2005;23:539-550.
52. Takeuchi M, Baichwal VR. Induction of the gene encoding mucosal vascular addressin cell adhesion molecule 1 by tumor necrosis factor α is mediated by NF-κB proteins. Proc Natl Acad Sci U S A. 1995;92:3561-3565.
53. -/- mice causes impaired lymph node development and lymphocyte recruitment. J Immunol. 2004;173:2271-2279.